The Financial Supervisory Commission (FSC) has eased the rules on consumer identity authentication for the online insurance business, enabling insurers to cooperate with non-insurance firms to speed up authentication.
Non-insurance firms include Chunghwa Post Co (中華郵政), online platforms that sell airline tickets or travel programs, mobile devices retailers, electric scooter manufactures and diabetes care apps, the commission said.
To team up with non-insurance firms to market new products, insurers earlier this year asked the commission to relax the rules on consumer identity authentication, Insurance Bureau Director-General Shih Chiung-hwa (施瓊華) told the Taipei Times by telephone yesterday.
Under the previous rules, customers of non-insurance companies needed to pass the firms’ identity authentication protocols when logging on to their platforms or apps, and then had to pass insurers’ identity authentication protoclos to buy products, Shih said.
The relaxed rules require people to pass only one identification control, which would save time and could boost their willingness to buy insurance policies, Shih added.
Reviews have also found that the identification protocols used by non-insurance companies, such as Chunghwa Post, Gogoro Inc (睿能創意) and H2 Inc (慧康生活) are robust and workable, she said.
Nan Shan Life Insurance Co (南山人壽) plans to partner with Gogoro to launch new usage-based insurance products, while other insurers would work with Chunghwa Post and H2 to market fire and earthquake insurance products, and health insurance for people with diabetes respectively, she added.
The commission allows Gogoro, Chunghwa Post and H2 to market the insurance policies provided by their partners on their Web sites or apps after users pass identity authentication, Shih said.
If insurance firms want to cooperate with non-insurance firms on consumer identity authentication, they need to apply to the commission, as the authentication mechanism must be reliable, she added.
KEEPING UP: The acquisition of a cleanroom in Taiwan would enable Micron to increase production in a market where demand continues to outpace supply, a Micron official said Micron Technology Inc has signed a letter of intent to buy a fabrication site in Taiwan from Powerchip Semiconductor Manufacturing Corp (力積電) for US$1.8 billion to expand its production of memory chips. Micron would take control of the P5 site in Miaoli County’s Tongluo Township (銅鑼) and plans to ramp up DRAM production in phases after the transaction closes in the second quarter, the company said in a statement on Saturday. The acquisition includes an existing 12 inch fab cleanroom of 27,871m2 and would further position Micron to address growing global demand for memory solutions, the company said. Micron expects the transaction to
Nvidia Corp’s GB300 platform is expected to account for 70 to 80 percent of global artificial intelligence (AI) server rack shipments this year, while adoption of its next-generation Vera Rubin 200 platform is to gradually gain momentum after the third quarter of the year, TrendForce Corp (集邦科技) said. Servers based on Nvidia’s GB300 chips entered mass production last quarter and they are expected to become the mainstay models for Taiwanese server manufacturers this year, Trendforce analyst Frank Kung (龔明德) said in an interview. This year is expected to be a breakout year for AI servers based on a variety of chips, as
Global semiconductor stocks advanced yesterday, as comments by Nvidia Corp chief executive officer Jensen Huang (黃仁勳) at Davos, Switzerland, helped reinforce investor enthusiasm for artificial intelligence (AI). Samsung Electronics Co gained as much as 5 percent to an all-time high, helping drive South Korea’s benchmark KOSPI above 5,000 for the first time. That came after the Philadelphia Semiconductor Index rose more than 3 percent to a fresh record on Wednesday, with a boost from Nvidia. The gains came amid broad risk-on trade after US President Donald Trump withdrew his threat of tariffs on some European nations over backing for Greenland. Huang further
Sweeping policy changes under US Secretary of Health and Human Services Robert F. Kennedy Jr are having a chilling effect on vaccine makers as anti-vaccine rhetoric has turned into concrete changes in inoculation schedules and recommendations, investors and executives said. The administration of US President Donald Trump has in the past year upended vaccine recommendations, with the country last month ending its longstanding guidance that all children receive inoculations against flu, hepatitis A and other diseases. The unprecedented changes have led to diminished vaccine usage, hurt the investment case for some biotechs, and created a drag that would likely dent revenues and
RSS